Myriad Genetics, Inc. (MYGN)
3.413
+0.05
(+1.58%)
USD |
NASDAQ |
Sep 11, 16:00
3.413
0.00 (0.00%)
After-Hours: 17:27
Myriad Genetics Gross Profit (TTM) : 525.10M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 525.10M |
| March 31, 2026 | 548.30M |
| December 31, 2025 | 552.80M |
| September 30, 2025 | 563.40M |
| June 30, 2025 | 566.80M |
| March 31, 2025 | 560.90M |
| December 31, 2024 | 553.50M |
| September 30, 2024 | 526.80M |
| June 30, 2024 | 511.10M |
| March 31, 2024 | 489.70M |
| December 31, 2023 | 474.20M |
| September 30, 2023 | 463.40M |
| June 30, 2023 | 435.60M |
| March 31, 2023 | 439.90M |
| December 31, 2022 | 435.30M |
| September 30, 2022 | 426.80M |
| June 30, 2022 | 438.90M |
| March 31, 2022 | 441.70M |
| December 31, 2021 | 442.30M |
| September 30, 2021 | 378.70M |
| June 30, 2021 | 369.40M |
| March 31, 2021 | 377.50M |
| June 30, 2020 | 391.50M |
| March 31, 2020 | 499.70M |
| December 31, 2019 | 553.90M |
| Date | Value |
|---|---|
| September 30, 2019 | 572.90M |
| June 30, 2019 | 590.80M |
| March 31, 2019 | 580.20M |
| December 31, 2018 | 557.10M |
| September 30, 2018 | 542.00M |
| June 30, 2018 | 529.30M |
| March 31, 2018 | 548.40M |
| December 31, 2017 | 571.30M |
| September 30, 2017 | 589.20M |
| June 30, 2017 | 600.20M |
| March 31, 2017 | 588.70M |
| December 31, 2016 | 586.40M |
| September 30, 2016 | 587.00M |
| June 30, 2016 | 596.50M |
| March 31, 2016 | 602.40M |
| December 31, 2015 | 595.79M |
| September 30, 2015 | 589.63M |
| June 30, 2015 | 573.50M |
| March 31, 2015 | 578.89M |
| December 31, 2014 | 591.51M |
| September 30, 2014 | 622.90M |
| June 30, 2014 | 668.51M |
| March 31, 2014 | 662.76M |
| December 31, 2013 | 642.58M |
| September 30, 2013 | 593.91M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Natera, Inc. | 1.753B |
| Sera Prognostics, Inc. | -0.86M |
| BioRestorative Therapies, Inc. | 0.119M |
| CareDx, Inc. | 321.18M |
| Exagen, Inc. | 41.70M |